1ITO image
Entry Detail
PDB ID:
1ITO
Keywords:
Title:
Crystal Structure Analysis of Bovine Spleen Cathepsin B-E64c complex
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2002-01-19
Release Date:
2003-01-19
Method Details:
Experimental Method:
Resolution:
2.29 Å
R-Value Free:
0.23
R-Value Work:
0.19
Space Group:
P 43 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Cathepsin B
Chain IDs:A
Chain Length:256
Number of Molecules:1
Biological Source:Bos taurus
Ligand Molecules
Primary Citation
Structural basis for development of cathepsin B-specific noncovalent-type inhibitor: crystal structure of cathepsin B-E64c complex
BIOCHIM.BIOPHYS.ACTA 1597 244 251 (2002)
PMID: 12044902 DOI: 10.1016/S0167-4838(02)00284-4

Abstact

In order to elucidate the substrate specificity of the Sn subsites (n=1-3) of cathepsin B, its crystal structure inhibited by E64c [(+)-(2S,3S)-3-(1-[N-(3-methylbutyl)amino]-leucylcarbonyl)oxirane-2-carboxylic acid] was analyzed by the X-ray diffraction method. Iterative manual rebuilding and convenient conjugate refinement of structure decreased R- and free R-factors to 19.7% and to 23.9%, respectively, where 130 water molecules were included for the refinement using 14,759 independent reflections from 10 to 2.3 A resolution. The epoxy carbonyl carbon of E64c was covalently bonded to the Cys(29) S(gamma) atom and the remaining parts were located at Sn subsites (n=1-3). The substrate specificity of these subsites was characterized based on their interactions with the inhibitor. Base on these structural data, we developed a novel cathepsin B-specific noncovalent-type inhibitor, which may bind to S2'-S3. The molecular design of possessing structural elements of both CA074 and E64c, assisted by energy minimization and molecular dynamics (MD) simulation, may lead to a new lead noncovalent-type inhibitor.

Legend

Protein

Chemical

Disease

Primary Citation of related structures